China Resources Double-Crane Pharmaceutical Co.,Ltd. Stock
Equities
600062
CNE000000Q94
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.57 CNY | +1.16% | +8.27% | +26.72% |
May. 08 | CR Double-Crane Pharmaceutical's Unit Gets Nod for Lidocaine Hydrochloride Injection | MT |
Apr. 26 | CR Double-Crane Pharmaceutical's Profit Rises 11% in Q1 as Revenue Grows 2% | MT |
Sales 2024 * | 11.36B 1.57B | Sales 2025 * | 12.64B 1.75B | Capitalization | 24.06B 3.33B |
---|---|---|---|---|---|
Net income 2024 * | 1.52B 211M | Net income 2025 * | 1.71B 237M | EV / Sales 2024 * | 2.12 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.9 x |
P/E ratio 2024 * |
16.1
x | P/E ratio 2025 * |
14.3
x | Employees | - |
Yield 2024 * |
1.27% | Yield 2025 * |
1.44% | Free-Float | 38.65% |
1 day | +1.16% | ||
1 week | +8.27% | ||
Current month | +8.27% | ||
1 month | +15.65% | ||
3 months | +24.12% | ||
6 months | +36.40% | ||
Current year | +26.72% |
Managers | Title | Age | Since |
---|---|---|---|
Wen Chao Lu
CHM | Chairman | - | 23-09-20 |
Li Hong Zheng
IRC | Investor Relations Contact | - | - |
Zhiyong Ge
PRN | Corporate Officer/Principal | 61 | 06-06-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ning Liu
BRD | Director/Board Member | 66 | 06-05-29 |
Wei Zheng
BRD | Director/Board Member | 64 | 18-06-21 |
Wen Chao Lu
CHM | Chairman | - | 23-09-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 23.57 | +1.16% | 12,928,940 |
24-05-09 | 23.3 | +1.84% | 15,423,250 |
24-05-08 | 22.88 | -1.00% | 14,612,610 |
24-05-07 | 23.11 | +0.39% | 18,035,740 |
End-of-day quote Shanghai S.E., May 09, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+26.72% | 3.33B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- 600062 Stock